Background: Tuberculosis (TB) remains the number one killer infectious disease in developing countries. There were an estimated 8.8 million incident cases of TB (range, 8.5 million-9.2 million) globally in 2010. Most of the estimated number of cases in 2010 occurred in Asia (59%) and Africa (26%). India alone accounted for an estimated one quarter (26%) of all TB cases worldwide. The clinical manifestations of TB could be either Pulmonary or Extra pulmonary (EPTB), the former being the commonest. In India, EPTB accounts for 10 to 15 percent of all types of TB. Mycobacterium tuberculosis complex shares high genomic similarities. Genotyping of M. tuberculosis helps in tracking the transmission links between individuals, and demonstrated instances in which epidemiologically linked people were in fact, infected with unrelated strains.Methods: Spacer-oligonucleotide typing and 12 loci mycobacterial interspersed repetitive units (MIRU) were performed to find genetic profiles of M. tuberculosis strains isolated from extrapulmonary tuberculosis patients. The spoligotyping results were compared with the world Spoligotyping Database of Institute Pasteur de Guadeloupe (SpolDB4). One hundred twenty five isolates of extrapulmonary tuberculosis were characterized and their drug susceptibility test (DST) was performed using BACTEC MGIT 960Results: Based on the spoligotyping method, 110 strains displayed known patterns and 15 isolates were absent in the database. Predominant spoligotypes belonged to the CAS family (57.27%). Overall, 28 different patterns were identified, including 12 clusters and 16 unique patterns. The largest clade comprised 38 strains belonging to the CAS1 DEL lineage. The combination of spoligotyping and 12-loci MIRU demonstrated maximal discriminatory power. We observed a significant association between Beijing family strains and drug-resistance. Conclusion:The present study demonstrated that CAS family isolates were the most prevalent genotype in extrapulmonary tuberculosis. Spoligotyping in combination with 12-loci MIRU is the most discriminatory tool for epidemiological analysis of M. tuberculosis from extrapulmonary tuberculosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.